Keyphrases
Inhalable
100%
Amorphization
100%
Arginine
100%
Budesonide
100%
Spray Drying
100%
Dry Powder
100%
Temperature-modulated Differential Scanning Calorimetry
18%
Feed Solution
18%
Particulate Properties
18%
Amorphous Powder
18%
Physical Stability
18%
Experimental Factors
9%
Differential Scanning Calorimetry Analysis
9%
Aerodynamic Properties
9%
Scanning Electron Microscopy
9%
Particle Morphology
9%
Amide Group
9%
Aerodynamic Diameter
9%
Emitted Dose
9%
Fine Particle Fraction
9%
Manufacturing Approaches
9%
Room Temperature
9%
FTIR Analysis
9%
Drying Conditions
9%
Attenuated Total reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR)
9%
Inhalable Dry Powder
9%
Solid Concentration
9%
Carbonyl Group
9%
Amorphous Drug
9%
High Solids Concentration
9%
Amorphous Nature
9%
Ethanol Concentration
9%
Solid-state Characterization
9%
Hydrogen Bonds (H-bonds)
9%
Lung Inflammation
9%
X-ray Powder Diffraction
9%
High Ethanol Concentration
9%
Aerodynamic Particle Sizer
9%
Amorphous Phase
9%
Manufacturing Methods
9%
Amino Acids
9%
Pharmacology, Toxicology and Pharmaceutical Science
Arginine
100%
Budesonide
100%
Differential Scanning Calorimetry
18%
Scanning Electron Microscopy
9%
Fourier Transform Infrared Spectroscopy
9%
Carboxamide
9%
Amino Acid
9%
Carbonyl Derivative
9%
Pneumonia
9%